This is a working overview of Preclinical research, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-08-02. Anything still debated is marked as such rather than presented as settled.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Regulatory treatment varies by country. Dihexa does not appear in major pharmacopeias as a licensed therapeutic substance. Suppliers may use labels such as research use only or not for human consumption. Such labels reflect legal and quality-control boundaries rather than evidence of clinical benefit. Importation, possession, and sale can be restricted depending on local laws, and enforcement focuses on claims, distribution channels, and product categories. These rules can change, and they differ from rules for approved medicines.
Dihexa is a synthetic peptide studied in preclinical neuroscience. It is often described as an angiotensin IV analog or derivative. The compound also appears under research codes such as PNB-0408 and N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. It is not an approved drug, and it is not a conventional vitamin or nutrient. In many jurisdictions, material sold as dihexa is handled as a research chemical rather than a medicine or supplement. This classification affects how the material is labeled and distributed.
Chemically, dihexa is a short peptide-like molecule with nonstandard components. Its structure includes tyrosine and isoleucine residues linked to a hexanoic acid group and an aminohexanoic amide segment. This design distinguishes it from endogenous angiotensin IV, though the two are discussed together because of shared origins. Published summaries classify it as a small synthetic peptide with lipophilic features that may influence how it crosses biological barriers in experimental systems. Exact conformational details depend on the specific salt or free base form.
| Property | Value | Notes |
|---|---|---|
| Common name | Dihexa | Shorthand used in research literature and supplier catalogs. |
| CAS Registry Number | 1401708-83-5 | Identifier assigned to the synthetic peptide. |
| Molecular formula | C27H44N4O5 | Reported formula; verify with a certificate of analysis. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Typical storage | −20 °C or below, desiccated | Common condition for peptide stability. |
Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.
Dihexa is a synthetic peptide-like compound studied in preclinical research for its reported effects on synaptic growth and cognitive measures in animal models. It is often described as an analog of angiotensin IV, a naturally occurring peptide fragment. The compound has not been approved as a medicine in any major jurisdiction. Most public information comes from laboratory studies, patents, and online vendor listings rather than from large clinical trials. Its scientific status therefore differs from that of an established pharmaceutical.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
It is perfectly legitimate to write [H+] for the hydronium ion concentration, since the state of solvation of the proton is constant (in dilute solutions) and so does not affect the equilibrium concentrations. Kw varies with variation in ionic strength and/or temperature. The concentrations of H+ and OH− are not independent quantities. Most commonly [OH−] is replaced by Kw[H+]−1 in equilibrium constant expressions which would otherwise include hydroxide ion. Solids also do not appear in the equilibrium constant expression, if they are considered to be pure and thus their activities taken to be one. An example is the Boudouard reaction:
Scholarly descriptions of what would now be recognized as dinosaur bones first appeared in the late 17th century in England. Part of a bone, now known to have been the femur of a Megalosaurus, was recovered from a limestone quarry at Cornwell near Chipping Norton, Oxfordshire, in 1676. The fragment was sent to Robert Plot, Professor of Chemistry at the University of Oxford and first curator of the Ashmolean Museum, who published a description in his The Natural History of Oxford-shire (1677). He correctly identified the bone as the lower extremity of the femur of a large animal, and recognized that it was too large to belong to any known species. He therefore concluded it to be the femur of a huge human, perhaps a Titan or another type of giant featured in legends. Edward Lhuyd, a friend of Sir Isaac Newton, published Lithophylacii Britannici ichnographia (1699), the first scientific treatment of what would now be recognized as a dinosaur. In it he described and named a sauropod tooth, "Rutellum impicatum", that had been found in Caswell, near Witney, Oxfordshire.
The analyte is already in an ion form in the solution, and it is desorbed as the solvent evaporates. Acid-base transfer. If the solvent is a buffer solution, then the analyte can ionize by exchanging a proton with the buffer. This form of ionization is well-suited for LC-MS, since the liquid used in liquid chromatography already is a buffer solution. Plasmaspray ionization or filament-on operation. The solvent in the spray is electron-ionized by an energetic electron beam. The ionized solvent then chemically ionizes the analyte. In ESI, the solution enters a capillary held at a high voltage (usually 2-5 kV), producing an electrospray into a heated chamber against a counterflow of a drying gas (usually nitrogen). This evaporates solvent molecules. The charge density increases on a droplet as it evaporates, until the electrostatic energy overcomes the surface tension energy, exploding the droplet. This process repeats, ending with an ion stream without the solvent. The ionization can occur by:
== Influence and reception == Saladino influenced low carb diet entrepreneur Dave Asprey and celebrity Heidi Montag. He has appeared on Joe Rogan's podcast, the first time in 2020, which greatly expanded his audience and profile. Alexei Anisin has written that his medical background and "pseudo-academic" style has allowed Saladino to give a perceived "scientific authority" to his content, while Saladino remains personally accessible to viewers, which in combination with the high production quality of his videos has led his viewers to trust him. Hafiz Rashid of The New Republic has described Saladino as an "infamous pseudoscience health influencer". According to science communicator Joseph A. Schwarcz, "Fearmongering has become an industry, and Saladino is a head honcho in this arena. The usual technique [for Saladino] is to pick a scientific study that finds some risk and then exaggerate it without taking into account type and extent of exposure." Schwarcz says that Saladino "thinks that lamb testicles and raw liver are healthy, and cruciferous vegetables like broccoli, Brussels sprouts, chard and kale are 'bulls–t.' These, Saladino says, should be avoided because 'once chewed they produce sulforaphane, which is toxic to humans.' Actually, sulforaphane has been shown to be an anti-carcinogen".
== Prognosis == The prognosis is quite dire, with early death usual. In fact, most patients die in their first year except in milder forms of the disease, but few are known to have lived longer. The variation is unsurprising given the diversity of mutations causing the disease.
Sources: en.wikipedia.org
=== Rumors and jokes === Rumors surrounding the initial use of lefse are the claims by Norwegian Americans that it was made by and used to sustain the Vikings, but potatoes were not introduced into Norway until long after the Vikings' time. Although many Scandinavian-Americans do enjoy and eat the foods of their ethnic traditions, there is no shortage of tall-tales and jokes surrounding certain food, as well. Lefse was not excluded from these rumors. Among other things, lefse has been said to be "so tasteless that many mistakenly eat the paper doily under the stack and do not know the difference."
=== Bankruptcy and sale to SPB Hospitality === On March 3, 2020, CraftWorks filed for Chapter 11 bankruptcy reorganization. At the same time, the company entered into an agreement with affiliates of Fortress Credit Co. LLC, its senior lenders, to sell the company for at least $138 million, plus the assumption of certain liabilities, CraftWorks said in a news release. However, Fortress Credit later withdrew a $23 million loan for continuing operations; it then agreed to fund $6 million to finance continuing operations, and on April 1, 2020, CraftWorks terminated nearly all 18,000 of their employees and terminated health care benefits as of March 31, 2020.
==== Sides are drawn ==== For the latter half of 2003; sides continued to be drawn in the feud as The Source magazine publicly showed support of Ja Rule's in the conflict. The magazine's co-owner at the time Raymond "Benzino" Scott took notice of the ongoing feud as he was involved in a separate public quarrel with Eminem, plausibly displaying his support for Ja Rule in a retaliatory act as Eminem had demonstrated full support for 50 Cent and G-Unit. The toll of the feud began to put itself on display for Ja Rule and Murder Inc by the latter half of 2003; the album Blood in My Eye was released on November 4, 2003 with a heavy emphasis on responding to the feud with both 50 Cent, G-Unit, and Eminem. Despite receiving mixed-to-positive reviews, Blood in My Eye failed to achieve a certification, selling a total of approximately 400,000 copies, indicative of the damage to Murder Inc's public image amidst the feud and their own legal issues with the federal government. Amidst the conflict, Ja Rule still had the support of various high-profile figures within the community, such as Fat Joe and Jadakiss who would go on to appear on Ja Rule's 2004 album R.U.L.E. in the form of the track New York. The album showed a slight return for Ja Rule commercially as it would outsell its predecessor and receive a gold certification, led by the success of New York as a single. The song continued to maintain tensions with 50 Cent and G-Unit as it was perceived to be a subliminal diss track against both 50 Cent and G-Unit member Lloyd Banks, mocking the latter's then-recent single "On Fire".
There are two tiers of local government covering Wilmslow, at parish (town) and unitary authority level: Wilmslow Town Council and Cheshire East Council. The town council is based at the Parish Hall on Cliff Road.
Under the 2017 constitution, prime ministers may only be chosen from a pre-declared list of candidates. Each party may submit up to three names and must have at least 5% (25 members) in the House of Representatives to receive eligibility. Candidates did not have to be a member of parliament (MP).
Sources: en.wikipedia.org
The mean lifetime of 238U (or any nuclide) is the half-life divided by ln(2) ≈ 0.693 (or multiplied by 1/ln(2) ≈ 1.443), which is about 2×1017 seconds, so 1 mole of 238U emits 3×106 alpha particles per second, producing the same number of thorium-234 atoms. In a closed system an equilibrium would be reached in which all members except the stable end-product have fixed ratios to one another, but in slowly decreasing amount. The amount of 206Pb will increase accordingly while that of 238U decreases; all steps in the decay chain have this same rate of 3×106 decayed particles per second per mole 238U. While 238U is minimally radioactive, its decay products, thorium-234 and protactinium-234, are beta particle emitters with half-lives of about 20 days and one minute respectively. Protactinium-234 decays to uranium-234, which has a half-life of hundreds of millennia, and this isotope does not reach an equilibrium concentration for a very long time. When the two first isotopes in the decay chain reach their relatively small equilibrium concentrations, a sample of initially pure 238U will emit three times the radiation due to 238U itself, and most of this radiation is beta particles. As already touched upon above, when starting with pure 238U, within a human timescale the equilibrium applies for the first three steps in the decay chain only. Thus, for one mole of 238U, 3×106 times per second one alpha and two beta particles and a gamma ray are produced, together 6.7 MeV, for a rate of 3 μW.
Blocking LRP5 expression using siRNA against LRP5 resulted in a significant decrease in MMP13 mRNA and protein expressions. The catabolic role of LRP5 appears to be mediated by the Wnt/beta-catenin pathway in human osteoarthritis. The polyphenol curcumin increases the mRNA expression of LRP5.
== Early life and education == Born in Thrissur, Kerala, Kallingal began practising dance at age 3. She was born to K. R. Rajan and Leenabhai at the Ayyanthole Kallingal family home in Thrissur district. She studied at Stanes Anglo-Indian School in Coonoor up to class 5, and completed her schooling at Chinmaya Vidyalaya in Thrissur, graduating in 2001. She holds a bachelor's degree in Journalism from Christ University, Bengaluru. She is also trained in Taekwondo, Chao (a Manipuri martial art), and Kalari. She joined the Bengaluru-based contemporary dance company Nritarutya after graduation and performed with the company on national and international stages before transitioning to acting. She was a semi-finalist on the Asianet reality show Vodafone Thakadhimi, and later participated in the Miss Kerala 2008 beauty pageant, placing first runner-up to Shree Thulasi in a tie-breaker.
=== Hall effect sensors === Due to extremely high electron mobility, graphene may be used for production of highly sensitive Hall effect sensors. Potential application of such sensors is connected with DC current transformers for special applications. New record high sensitive Hall sensors are reported in April 2015. These sensors are two times better than existing Si based sensors.
== Function == G protein-coupled receptors (GPCRs, or GPRs) contain 7 transmembrane domains and transduce extracellular signals through heterotrimeric G proteins. A 26-amino acid RF-amide peptide, P518 functions as a high-affinity ligand of GPR103. Both GPR103 and P518 precursor mRNA exhibited highest expression in brain. The 43-amino acid QRFP peptide, a longer form of the P518 peptide is necessary to exhibit full agonistic activity with GPR103. Intravenous administration QRFP caused release of aldosterone, suggesting that QRFP and GPR103 regulate adrenal function.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.
It is produced by chemical synthesis, not extracted from plants or animals. Its design is based on a naturally occurring peptide fragment. Suppliers sell it as a research chemical.
No, dihexa is a modified analog of angiotensin IV. The two share a structural relationship but differ in chemical details. Research on one does not automatically apply to the other.
It is a synthetic peptide analog of angiotensin IV studied mainly in laboratory and animal research. It is not an approved medicine. Human clinical data are limited.